# Reduce Immunosuppression With Atmp in NS ChildrEn

> **NCT04034316** · PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 20 (actual)

## Conditions studied

- Nephrotic Syndrome in Children
- Steroid-Dependent Nephrotic Syndrome
- Idiopathic Nephrotic Syndrome

## Interventions

- **OTHER:** Cord-blood mesenchymal stromal cells

## Key facts

- **NCT ID:** NCT04034316
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-02
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034316, "Reduce Immunosuppression With Atmp in NS ChildrEn". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04034316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*